Year: 2019

The agents of discovery: patenting and licensing ideas from bench to bedside

Posted by Gary Bridgman | Dec 12, 2019

Meet St. Jude’s tech transfer experts who patent and license researchers’ basic science discoveries to help patients worldwide.

Learn more

For new ideas and collaboration, St. Jude Global hosts neuro-oncology training seminar

Posted by Lance Wiedower | Dec 5, 2019

St. Jude Global Academy hosted a neuro-oncology seminar to generate new ideas for high-impact interventions and share experiences. Read more.

Learn more

Ending the HIV epidemic: A national plan to reduce HIV infections

Posted by Michael Sheffield | Nov 27, 2019

Ending the HIV Epidemic is a bold plan to reduce HIV infections by 90 percent nationally. On a local level, St. Jude aims to have no new HIV cases by 2030.

Learn more

Smithsonian honors St. Jude visionaries for ‘bubble boy’ cure

Posted by Mary Powers | Nov 19, 2019

Read how St. Jude researchers and clinicians used gene therapy to cure the diabolical bubble boy disease.

Learn more

Proteins: Playing with molecular rubber duckies

Posted by Marcus Fischer, PhD | Nov 18, 2019

Are you a match? Read how this molecule’s affinity to proteins can change according to water.

Learn more

New analytical technique reveals the subtle genetic differences among cancer cells

Posted by Xiang Chen, PhD | Nov 12, 2019

Sequencing data gives insights into what’s going on in a cell. It’s a lot of information. Read how scientists are finding ways to cut through the information and find causes for disease.

Learn more

Genetic sequencing: How do we put out the fires of genetically driven cancers?

Posted by Jill Bouchard, PhD | Nov 8, 2019

Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.

Learn more

Survivorship studies dig in on data

Posted by Kirsten Ness, PT, PhD, FAPTA | Nov 6, 2019

Read how cancer survivorship research reveals more about the late effects of treatment on children – and how the data can paint a more complete picture.

Learn more

Having those critical conversations about fertility after cancer

Posted by Maggie Besler, MD | Nov 5, 2019

As clinicians learn more about the late effects of pediatric cancer treatments, these important discussions with patients are changing.

Learn more

Research homes in on drug to dampen inflammation fueling life-threatening immune disorder

Posted by Mary Powers | Nov 1, 2019

Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.

Learn more